Intraday Price Movement and Circuit Trigger
On 18 Mar 2026, Venus Remedies Ltd (stock code 568580) opened with a positive gap of 2.2%, reaching an intraday high of ₹937, up 2.42% from the previous close. However, the optimism was short-lived as the stock reversed sharply, plunging to an intraday low of ₹869.2, a decline of 5% from the previous day’s close. This fall triggered the lower circuit price band of ₹869.2, capping further losses for the day.
The stock closed at ₹894.2, down 2.26% on the day, underperforming its sector by 2.83% and the broader Sensex, which gained 0.93%. The maximum loss of 5% intraday and the lower circuit hit indicate severe selling pressure overwhelming any buying interest.
Volume and Liquidity Analysis
Trading volumes were moderate, with total traded volume at approximately 45,794 shares (0.45794 lakh), generating a turnover of ₹4.13 crore. Notably, the weighted average price was closer to the day’s low, signalling that most trades occurred near the lower price levels, reinforcing the bearish sentiment.
Despite the micro-cap status of Venus Remedies, the stock demonstrated sufficient liquidity for trades up to ₹0.2 crore based on 2% of the 5-day average traded value, allowing for meaningful price discovery during the session.
Technical and Trend Indicators
Venus Remedies is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term bullish trend. However, the recent price action marks a reversal after two consecutive days of gains, signalling a potential short-term correction or profit booking phase.
Investor participation has notably declined, with delivery volume on 17 Mar falling by 64.41% compared to the 5-day average. This drop in delivery volume indicates reduced conviction among buyers, possibly contributing to the stock’s vulnerability to sharp declines.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Market Capitalisation and Sector Context
Venus Remedies Ltd is classified as a micro-cap company with a market capitalisation of approximately ₹1,246 crore. Operating within the Pharmaceuticals & Biotechnology sector, the stock’s performance is critical to watch given the sector’s sensitivity to regulatory developments, product pipelines, and broader market sentiment.
On the day of the decline, the sector itself posted a modest gain of 0.34%, highlighting that Venus Remedies’ underperformance was stock-specific rather than sector-driven. This divergence suggests company-specific factors or investor concerns may have triggered the sell-off.
Mojo Score and Rating Update
Venus Remedies currently holds a Mojo Score of 74.0, reflecting a positive outlook based on a combination of fundamental and technical parameters. The Mojo Grade was recently upgraded from Hold to Buy on 12 Mar 2026, signalling improved confidence in the stock’s medium-term prospects.
Despite the recent setback, the upgrade indicates that analysts and algorithmic models see value in the stock, potentially anticipating a recovery or sustained growth trajectory beyond the current volatility.
Investor Sentiment and Panic Selling
The sharp fall to the lower circuit limit is indicative of panic selling, where investors rush to exit positions amid uncertainty or negative triggers. The unfilled supply at lower price levels suggests that sellers overwhelmed buyers, pushing the stock down rapidly until the circuit breaker mechanism halted further declines.
This kind of price action often reflects a short-term imbalance between supply and demand rather than a fundamental deterioration. However, it also raises caution for investors to monitor upcoming news flow, earnings updates, or sector developments that could have precipitated the sell-off.
Want to dive deeper on Venus Remedies Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Investor Considerations
While the lower circuit hit signals immediate selling pressure, the stock’s longer-term technical indicators and recent upgrade to a Buy grade suggest that this may be a temporary correction. Investors should closely monitor trading volumes, delivery participation, and any corporate announcements that could influence sentiment.
Given the micro-cap nature of Venus Remedies, price volatility can be pronounced, and liquidity constraints may exacerbate sharp moves. Caution is advised for new entrants, while existing shareholders may consider the current dip as a potential entry point if fundamentals remain intact.
Comparatively, the stock’s underperformance against the sector and Sensex on 18 Mar 2026 highlights the importance of stock-specific analysis rather than broad market extrapolation.
Summary
Venus Remedies Ltd’s plunge to the lower circuit on 18 Mar 2026 underscores a day of heavy selling pressure and panic-driven exits. Despite opening strong, the stock succumbed to unrelenting supply, closing down 2.26% with a maximum intraday loss of 5%. The decline contrasts with sector and market gains, pointing to company-specific factors at play.
With a recent Mojo Grade upgrade to Buy and a solid Mojo Score of 74.0, the stock’s medium-term outlook remains cautiously optimistic. However, investors should remain vigilant to evolving market dynamics and liquidity conditions before making decisive moves.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
